**Core Concept**
Digoxin is a cardiac glycoside used in the management of atrial fibrillation, atrial flutter, and heart failure. It works by inhibiting the sodium-potassium ATPase pump, leading to an increase in intracellular calcium and thus enhancing contractility.

**Why the Correct Answer is Right**
The mechanism of action of digoxin involves the inhibition of the sodium-potassium ATPase pump, which increases intracellular calcium. This increase in calcium enhances contractility and slows the heart rate. However, digoxin is not indicated in cases of Wolff-Parkinson-White (WPW) syndrome, as it can exacerbate the condition by increasing the rate of conduction through the accessory pathway.

**Why Each Wrong Option is Incorrect**
* **Option A**: This is incorrect because digoxin is actually indicated in atrial fibrillation, which is a common arrhythmia characterized by rapid and irregular heart rhythms. Digoxin helps to control the ventricular rate in patients with atrial fibrillation.
* **Option B**: This option is incorrect because digoxin is indicated in heart failure, particularly in patients with mild to moderate symptoms. It helps to improve exercise tolerance and reduce symptoms of heart failure.
* **Option C**: This option is incorrect because digoxin is indicated in atrial flutter, which is a type of supraventricular tachycardia. Digoxin helps to control the heart rate and convert the arrhythmia to a normal sinus rhythm.

**Clinical Pearl / High-Yield Fact**
Digoxin toxicity can be caused by hypokalemia, hypomagnesemia, or hypercalcemia, which can lead to increased levels of digoxin in the body. It is essential to monitor these electrolytes closely in patients on digoxin therapy.

**Correct Answer: D. Wolff-Parkinson-White (WPW) syndrome**